The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
Abstract Background/aim N-Acetylcysteine (NAC) demonstrates applications in the prevention of exacerbation of chronic obstructive pulmonary disease (COPD). COPD is often characterized by fibrosis of the small airways. This study aims at investigating the physiological mechanisms by which NAC might m...
Main Authors: | Lanlan Zhu, Fei Xu, Xiuhua Kang, Jing Zhou, Qinqin Yao, Yang Lin, Wei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-021-00342-y |
Similar Items
-
Effect of N-acetylcysteine on pulmonary fibrosis, endothelial injury and vasoactive factors in patients with chronic pulmonary heart disease
by: Qi-Ping Chen
Published: (2017-06-01) -
Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis
by: L. R. Rodriguez, et al.
Published: (2019-06-01) -
von Willebrand factor promotes platelet-induced metastasis of osteosarcoma through activation of the VWF-GPIb axis
by: Q. Wang, et al.
Published: (2020-12-01) -
Beneficial effects of N-acetylcysteine on protease-antiprotease balance in attenuating bleomycin-induced pulmonary fibrosis in rats
by: Ritu Kulshrestha, et al.
Published: (2020-03-01) -
Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane <i>N</i>-acetylcysteine
by: Eun Suk Son, et al.
Published: (2021-06-01)